Log In
BCIQ
Print this Print this
 

GenePro

  Manage Alerts
Collapse Summary General Information
Company IGXBio Inc.
DescriptionDNA lentiviral immunotherapeutic that generates non-infective and non-replicative HIV viral like particles (VLPs) to stimulate the production of natural killer (NK) and CD8+ T cells
Molecular Target
Mechanism of Action 
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationHIV / AIDS
Indication DetailsHIV/AIDS
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/27/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today